default author photo

Cyrus Poonawalla

Serum Institute of India Private Ltd

SCHOLARLY PAPERS

2

DOWNLOADS

307

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

Safety and Immunogenicity of SII-NVX-CoV2373 (COVID-19 Vaccine) In Adults in a Phase 2/3, Observer-Blind, Randomised, Controlled Study

Number of pages: 31 Posted: 08 Jul 2022
Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR) - National AIDS Research Institute, Indian Council of Medical Research (ICMR) - National AIDS Research Institute, Dr. D. Y. Patil Medical College, Hospital & Research Centre - Dr. D. Y. Patil Medical College, Hospital & Research Centre, Students, Mahatma Gandhi Institute of Medical Sciences, Hamdard Institute of Medical Sciences & Research (HIMSR), University of Liverpool - School of Tropical Medicine, JSS Academy of Higher Education and Research, Institute of Medical Sciences & SUM Hospital, KLES Dr. Prabhakar Kore Hospital & M.R.C, KEM Hospital Research Centre - Vadu Budruk, Seth G S Medical College & KEM Hospital, Government Medical College, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), KIIT University - Kalinga Institute of Medical Sciences (KIMS), KIMS Hospital and Research Centre, Christian Medical College, Sahyadri Super Specialty Hospital, Pune, Acharya Vinoba Bhave Rural Hospital, Amrita Institute of Medical Science - Division of Infectious Disease, Noble Hospital, All India Institute of Medical Sciences (AIIMS), Bhopal, All India Institute of Medical Sciences (AIIMS), Gorakhpur, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, 360biolabs, Indian Council of Medical Research (ICMR), Indian Council of Medical Research–National AIDS Research Institute, Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR), Serum Institute of India Private Ltd, Serum Institute of India Private Ltd and Independent
Downloads 162 (461,984)
Citation 1

Abstract:

Loading...

SII-NVX-CoV2373, NVX-CoV2373, safety, immunogenicity, non-inferiority

2.

Safety and Immunogenicity of a Bivalent Paratyphoid A-Typhoid Conjugate Vaccine in Healthy Indian Adults: A Phase I, Randomized, Active Controlled Study

Number of pages: 26 Posted: 28 Aug 2023
Serum Institute of India Private Ltd, Serum Institute of India Pvt Ltd, Serum Institute of India Private Ltd, Syngene International Limited, Syngene International Limited, Syngene International Limited, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Emmes India Pvt, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group and Independent
Downloads 145 (508,926)
Citation 1

Abstract:

Loading...

Enteric fever, typhoid, paratyphoid, first-in-human